TNXP as of Nov 3 · 05:49 ET
TNXPNasdaqPharmaceutical Preparations

Tonix Pharmaceuticals Holding Corp. · Brief

Next report

6 days

Nov 9 · after closeest.Q3 FY26

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 4≥ implied
avg implied
±15.6%
avg realized
±4.0%
Nov 12 '24—▲+3.35%—
Mar 18 '25—▼−19.78%—
May 12 '25—▲+5.16%—
Aug 11 '25—▲+32.89%—
Q3 FY25±21.1%▲+4.10%×0.19
Q1 FY26±14.0%▼−1.27%×0.09
May 11 '26±14.3%▼−5.88%×0.41
Q2 FY26±13.0%▲+4.66%×0.36
quarterimplied−35%0+35%realized×
Q2 FY26±13.0%▲+4.66%×0.36
May '26±14.3%▼−5.88%×0.41
Q1 FY26±14.0%▼−1.27%×0.09
Q3 FY25±21.1%▲+4.10%×0.19
Aug '25—▲+32.89%—
May '25—▲+5.16%—
2 older reports
Mar '25—▼−19.78%—
Nov '24—▲+3.35%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2 of 3

3tracked funds holding TNXPN-PORT · Aug 31 '26
103managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

4 of 4recent reports where the move came in under the options-implied rangeEarnings history
0.01%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

TNXP report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 26impliedImplied move: ±24.1% into Nov 9 earnings (Oct 26 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.